ARCHIVES

FDA Hears More Criticism On Cancer Drug Endpoints; Joint Conferences On Criteria Recommended

This article is from The Cancer Letter archive.

Vol. 15 No. 30 | July 28, 1989

Download PDF Visit The Full Archive

Related Articles

Panel To Take Up Issues In Grant/Peer Review System, Consider NCAB Membership Requirements

December 11, 1981

Race, Age Play Role In Delay Of Surgery For Breast Cancer

December 28, 2007

President Asks $600 Million For NCI In ’75; Research Grants Would Get $19 Million Hike

February 8, 1974

Aggressive, Tailored Therapy Improves Survival, Study Finds

October 31, 2008

Proflavine Bioassay Ineffective, NCI Says

July 15, 1977

Home Test Detects Hematuria Earlier

August 4, 1989